Browsing by Author "Aguilar Company, Juan"
Now showing items 1-11 of 11
-
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Gudiol, Carlota; Durà-Miralles, X.; Aguilar Company, Juan; Hernández-Jiménez, P.; Martínez-Cutillas, M.; Fernandez-Avilés, F. (Elsevier, 2021-09) -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Garrigós Cubells, Laia; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Aguilar Company, Juan; Pla, Helena; Ruiz Camps, Isabel; Saura Manich, Cristina (SAGE Publications, 2021-11-02) -
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
Cortellini, Alessio; Gennari, Alessandra; Pommeret, Fanny; Patel, Grisma; Newsom-Davis, Thomas; Bertuzzi, Alexia Francesca; Aguilar Company, Juan; Mirallas Viñas, Oriol; Roldan Galvan, Elisa; Ruiz Camps, Isabel; Fox, Maria Laura (Oxford University Press, 2022-07) -
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Cortellini, Alessio; Dettorre, Gino M; Dafni, U.; Aguilar Company, Juan; Castelo-Branco, L.; Lambertini, Matteo (BMJ, 2022-11) -
Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases
Aguilar Company, Juan; Lopez-Olivo, Maria A.; Ruiz Camps, Isabel (Frontiers Media, 2022-07-15) -
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
Cortellini, Alessio; Aguilar Company, Juan; Salazar, Ramón; Bower, Mark; Sita-Lumsden, Ailsa; Plaja, Andrea (Springer Nature, 2022-11-09) -
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Ahmad Diaz, Faten; Villanueva, Rafael; Valdivia Vadell, Carolina; Palomino-Doza, Julián; Ruiz, Ada; Azaro Pedrazzoli, Analía Beatriz; Aguilar Company, Juan; Martín Pérez, Anastasio; Escriva de Romaní Muñoz, Santiago Ignacio; Alcalde Rodrigo, Maria; Ruiz Camps, Isabel; Bellet Ezquerra, Meritxell; Reyes López, Victoria (SAGE Publications, 2019-05-10) -
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
Pinato, David J.; Lee, Alvin J. X.; Biello, Federica; Seguí, Elia; Aguilar Company, Juan; Carbó, Anna; Ruiz Camps, Isabel; Tabernero Caturla, Josep (MDPI, 2020-07-08) -
Risk of infection associated with targeted therapies for solid organ and hematological malignancies
Ruiz Camps, Isabel; Aguilar Company, Juan (SAGE Publications, 2021-02-19) -
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Soosaipillai, Gehan; Wu, Anjui; Dettorre, Gino M; Diamantis, Nikolaos; Chester, John; Moss, Charlotte; Aguilar Company, Juan; Ruiz Camps, Isabel; Cabirta Touzon, Alba; Tabernero Caturla, Josep; Saoudi Gonzalez, Nadia (SAGE Publications, 2021-09-02) -
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Dettorre, Gino M; Dolly, Saoirse; Loizidou, Angela; Chester, John; Jackson, Amanda; Mukherjee, Uma; Aguilar Company, Juan; Mirallas Viñas, Oriol; García Illescas, David; Ruiz Camps, Isabel; Tabernero Caturla, Josep; Saoudi Gonzalez, Nadia (BMJ Publishing Group, 2021-03-22)